id.exposure	id.outcome	outcome	exposure	method	Q	Q_df	Q_pval
GCST90277240	finn-b-I9_PVT_EXNONE	finn-b-I9_PVT_EXNONE	Sterol ester (27:1/16:0) levels	Inverse variance weighted	23.5459088818195	33	0.887596997514504
GCST90277240	finn-b-I9_PVT_EXNONE	finn-b-I9_PVT_EXNONE	Sterol ester (27:1/16:0) levels	MR Egger	23.532687542625	32	0.860830259368787
GCST90277245	finn-b-I9_PVT_EXNONE	finn-b-I9_PVT_EXNONE	Sterol ester (27:1/18:1) levels	Inverse variance weighted	29.6511431524282	30	0.483620008820457
GCST90277245	finn-b-I9_PVT_EXNONE	finn-b-I9_PVT_EXNONE	Sterol ester (27:1/18:1) levels	MR Egger	29.611103371782	29	0.433601771217982
GCST90277259	finn-b-I9_PVT_EXNONE	finn-b-I9_PVT_EXNONE	Diacylglycerol (16:0_18:2) levels	Inverse variance weighted	32.4496094572438	27	0.21584183936469
GCST90277259	finn-b-I9_PVT_EXNONE	finn-b-I9_PVT_EXNONE	Diacylglycerol (16:0_18:2) levels	MR Egger	31.6682899622898	26	0.204317462804937
GCST90277268	finn-b-I9_PVT_EXNONE	finn-b-I9_PVT_EXNONE	Phosphatidylcholine (20:4_0:0) levels	Inverse variance weighted	23.9763658474178	24	0.462949490705544
GCST90277268	finn-b-I9_PVT_EXNONE	finn-b-I9_PVT_EXNONE	Phosphatidylcholine (20:4_0:0) levels	MR Egger	23.9320315019554	23	0.407580149620778
GCST90277277	finn-b-I9_PVT_EXNONE	finn-b-I9_PVT_EXNONE	Phosphatidylcholine (16:0_16:0) levels	Inverse variance weighted	24.893339001962	24	0.411575356656553
GCST90277277	finn-b-I9_PVT_EXNONE	finn-b-I9_PVT_EXNONE	Phosphatidylcholine (16:0_16:0) levels	MR Egger	24.5099316095751	23	0.376037773595446
GCST90277290	finn-b-I9_PVT_EXNONE	finn-b-I9_PVT_EXNONE	Phosphatidylcholine (16:0_22:5) levels	Inverse variance weighted	21.3905283417527	28	0.808695004358748
GCST90277290	finn-b-I9_PVT_EXNONE	finn-b-I9_PVT_EXNONE	Phosphatidylcholine (16:0_22:5) levels	MR Egger	21.3526894627337	27	0.769497833121459
GCST90277299	finn-b-I9_PVT_EXNONE	finn-b-I9_PVT_EXNONE	Phosphatidylcholine (18:0_18:1) levels	Inverse variance weighted	31.8874969760533	29	0.324833210391476
GCST90277299	finn-b-I9_PVT_EXNONE	finn-b-I9_PVT_EXNONE	Phosphatidylcholine (18:0_18:1) levels	MR Egger	30.3861911021555	28	0.344998676968038
GCST90277311	finn-b-I9_PVT_EXNONE	finn-b-I9_PVT_EXNONE	Phosphatidylcholine (18:1_20:2) levels	Inverse variance weighted	18.0814233144459	22	0.701149958423511
GCST90277311	finn-b-I9_PVT_EXNONE	finn-b-I9_PVT_EXNONE	Phosphatidylcholine (18:1_20:2) levels	MR Egger	15.2663662575675	21	0.809352900327128
GCST90277313	finn-b-I9_PVT_EXNONE	finn-b-I9_PVT_EXNONE	Phosphatidylcholine (18:1_20:4) levels	Inverse variance weighted	16.2549134113114	27	0.947913084936989
GCST90277313	finn-b-I9_PVT_EXNONE	finn-b-I9_PVT_EXNONE	Phosphatidylcholine (18:1_20:4) levels	MR Egger	15.9004383789754	26	0.938568841666372
GCST90277324	finn-b-I9_PVT_EXNONE	finn-b-I9_PVT_EXNONE	Phosphatidylcholine (O-16:0_22:5) levels	Inverse variance weighted	11.3668260978382	16	0.78629717314416
GCST90277324	finn-b-I9_PVT_EXNONE	finn-b-I9_PVT_EXNONE	Phosphatidylcholine (O-16:0_22:5) levels	MR Egger	11.348717336117	15	0.727505466348995
GCST90277340	finn-b-I9_PVT_EXNONE	finn-b-I9_PVT_EXNONE	Phosphatidylcholine (O-18:1_20:4) levels	Inverse variance weighted	10.8239242654961	21	0.966106944612546
GCST90277340	finn-b-I9_PVT_EXNONE	finn-b-I9_PVT_EXNONE	Phosphatidylcholine (O-18:1_20:4) levels	MR Egger	9.10143511996425	20	0.981702344435406
GCST90277348	finn-b-I9_PVT_EXNONE	finn-b-I9_PVT_EXNONE	Phosphatidylethanolamine (18:0_20:4) levels	Inverse variance weighted	22.0079030130969	20	0.34008195730207
GCST90277348	finn-b-I9_PVT_EXNONE	finn-b-I9_PVT_EXNONE	Phosphatidylethanolamine (18:0_20:4) levels	MR Egger	20.1140859118093	19	0.387742724413453
GCST90277353	finn-b-I9_PVT_EXNONE	finn-b-I9_PVT_EXNONE	Phosphatidylethanolamine (O-18:1_18:2) levels	Inverse variance weighted	29.5800832452774	28	0.383566145492602
GCST90277353	finn-b-I9_PVT_EXNONE	finn-b-I9_PVT_EXNONE	Phosphatidylethanolamine (O-18:1_18:2) levels	MR Egger	29.3726002389492	27	0.343067404522639
GCST90277359	finn-b-I9_PVT_EXNONE	finn-b-I9_PVT_EXNONE	Phosphatidylinositol (16:0_18:2) levels	Inverse variance weighted	15.9630303799498	22	0.817716373826666
GCST90277359	finn-b-I9_PVT_EXNONE	finn-b-I9_PVT_EXNONE	Phosphatidylinositol (16:0_18:2) levels	MR Egger	15.1144665336605	21	0.817164675539885
GCST90277363	finn-b-I9_PVT_EXNONE	finn-b-I9_PVT_EXNONE	Phosphatidylinositol (18:0_20:3) levels	Inverse variance weighted	33.1554198511459	33	0.45967750254711
GCST90277363	finn-b-I9_PVT_EXNONE	finn-b-I9_PVT_EXNONE	Phosphatidylinositol (18:0_20:3) levels	MR Egger	32.1799437488371	32	0.457843856550266
GCST90277373	finn-b-I9_PVT_EXNONE	finn-b-I9_PVT_EXNONE	Sphingomyelin (d36:2) levels	Inverse variance weighted	22.5189354309004	24	0.548323210556028
GCST90277373	finn-b-I9_PVT_EXNONE	finn-b-I9_PVT_EXNONE	Sphingomyelin (d36:2) levels	MR Egger	22.5050250497235	23	0.48996478270755
GCST90277402	finn-b-I9_PVT_EXNONE	finn-b-I9_PVT_EXNONE	Triacylglycerol (53:3) levels	Inverse variance weighted	20.9270181405162	24	0.643026849237279
GCST90277402	finn-b-I9_PVT_EXNONE	finn-b-I9_PVT_EXNONE	Triacylglycerol (53:3) levels	MR Egger	20.0195135520711	23	0.640734346286857
GCST90277404	finn-b-I9_PVT_EXNONE	finn-b-I9_PVT_EXNONE	Triacylglycerol (54:3) levels	Inverse variance weighted	32.7136586777685	29	0.289438083813737
GCST90277404	finn-b-I9_PVT_EXNONE	finn-b-I9_PVT_EXNONE	Triacylglycerol (54:3) levels	MR Egger	32.0071002294091	28	0.274222078406025
GCST90277409	finn-b-I9_PVT_EXNONE	finn-b-I9_PVT_EXNONE	Triacylglycerol (56:3) levels	Inverse variance weighted	23.9277572690854	23	0.40781786374461
GCST90277409	finn-b-I9_PVT_EXNONE	finn-b-I9_PVT_EXNONE	Triacylglycerol (56:3) levels	MR Egger	22.4744747033334	22	0.431892342035911
